Real-time enrollment status for this advanced solid tumor clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 1:53 AM UTC
| NCT Number | NCT06597721 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumor |
| Phase | PHASE1 |
| Target Enrollment | 210 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Adcendo ApS |
| Last Updated on CT.gov | September 9, 2026 (Sep 9, 2026) |
As of October 15, 2026: Clinical trial NCT06597721 is currently recruiting participants. This phase1 study for advanced solid tumor is actively seeking new participants at 7 locations across the United States. The study is sponsored by Adcendo ApS. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06597721 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06597721 was last updated Sep 9, 2026 (September 9, 2026). HelloStudys verifies this status automatically.